Your browser doesn't support javascript.
loading
Seizures in febrile children with SARS-CoV-2 infection: clinical features, short-term follow-up.
Jiang, Jipeng; Shen, Zhengsong; Cao, Jie.
  • Jiang J; Department of General Medicine, Nation Clinical Research Center for Child Health and Disorders, Ministry of Education Key Labiratory of Child Development and Disorders, Childrens Hospital of Chongqing Medical University, No.136 Zhongshan 2nd Road, Yuzhong District, Chongqing, China.
  • Shen Z; China International Science and Technology Cooperation base of Child development and Critical Disorders, No.136 Zhongshan 2nd Road, Yuzhong District, Chongqing, China.
  • Cao J; Chongqing Key Laboratory of Pediatrics, No.136 Zhongshan 2nd Road, Yuzhong District, Chongqing, China.
BMC Pediatr ; 24(1): 257, 2024 Apr 17.
Article en En | MEDLINE | ID: mdl-38627666
ABSTRACT

BACKGROUND:

As the Omicron variant of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerges, the neurological manifestations correlated with this epidemic have garnered increasing attention. This study was primarily intended to compare seizures in febrile children with and without SARS-CoV-2 infection and to conduct short-term follow-up of the SARS-CoV-2-infected patients.

METHODS:

Retrospective analysis of patients admitted to the Children's Hospital of Chongqing Medical University for fever and seizures between October 1 and December 30, 2022. Based on the results of SARS-CoV-2 Reverse Transcription-Polymerase Chain Reaction(RT-PCR) at the time of admission, the patients were divided into a Coronavirus disease 2019(COVID-19) positive group and a COVID-19 negative group. Aside from that, we followed up COVID-19-positive patients for 3 months after their discharge from the hospital. The follow-up included monitoring for post-discharge seizures.

RESULTS:

Compared with the COVID-19-negative group, the COVID-19-positive group had a higher proportion of seizure duration ≥ 15 min(18.7%VS5.1%;P = 0.001), seizure ≥ 2 time(54.4%VS41.0%; P = 0.024), status epilepticus(15.4%VS5.1%; P = 0.005), and Electroencephalogram (EEG) abnormalities(29.4%VS13.6%; P = 0.016). Among the 161 individuals under follow-up, 21 (13.0%)experienced a recurrence of seizures.

CONCLUSIONS:

Although the incidence of seizure duration ≥ 15 min, number of seizures ≥ 2 time, and status epilepticus was higher in the COVID-19-positive group, the majority of patients had a favorable prognosis. Nonetheless, patients with COVID-19 who present with seizures and persistent impaired consciousness need to be alerted to serious neurological disorders such as acute necrotizing encephalopathy. Owing to the consideration that some patients may experience a recurrence of seizures within a short period of time, it is paramount to provide guardians with education about the emergency management of seizures and to follow up with patients over time.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estado Epiléptico / COVID-19 Límite: Child / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Estado Epiléptico / COVID-19 Límite: Child / Humans Idioma: En Año: 2024 Tipo del documento: Article